卖什么
莱姆病和性传播感染的居家分子检测。
商业模式拆解
买家：谁掌握预算？
未核实Consumers (at-home kits) and clinics/health systems; partners commissioning diagnostics.
触发点：什么让他们现在购买？
Lyme symptoms and antibodies appear weeks or months after a tick bite, leaving the disease undiagnosed; a test usable right after a bite fills the gap.
工作流：什么输入变成什么输出？
Sample skin interstitial fluid at the bite site, run a single-step, single-temperature freeze-dried paper-based molecular assay in a single-use cassette, read a visual result in about 30 minutes.
经济账：省了什么，怎么收费？
Sells single-use diagnostic kits and custom diagnostic development; claims 98% accuracy vs PCR and 100% specificity, with tests prototyped in days.
渠道：怎么接触到客户？
Waitlist for launch; Lyme disease early detection kits and CT/NG (chlamydia, gonorrhoea) tests offered.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-07-10 | — | €5M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.